Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
GT Biopharma, Inc. (GTBP) had Earnings per Share (EPS) (Basic) of $-0.33 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.78M |
|
-- |
|
-- |
|
$1.93M |
|
$-1.93M |
|
$1.16M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-0.78M |
|
$-1.93M |
|
$-1.93M |
|
2.35M |
|
2.35M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.33 |
$-0.33 |
|
| Balance Sheet Financials | |
$2.66M |
|
-- |
|
-- |
|
$2.66M |
|
$3.64M |
|
-- |
|
-- |
|
$3.64M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
2.54M |
|
| Cash Flow Statement Financials | |
$-2.20M |
|
-- |
|
$0.62M |
|
$4.04M |
|
$2.46M |
|
$-1.59M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
79.10% |
|
79.18% |
|
-29.19% |
|
79.18% |
|
$-0.39 |
|
$-0.94 |
|
$-0.94 |
|